• Return to Headlines

Shares of CR Bard Rise Above Previous 52-Week High

By Amy Schwartz

CR Bard (NYSE:BCR) traded today at a new 52-week high of $315.18. So far today approximately 94,000 shares have been exchanged, as compared to an average 30-day volume of 460,000 shares.

CR Bard (NYSE:BCR) is currently priced 20.6% above its average consensus analyst price target of $249.13. The stock should find initial support at its 50-day moving average (MA) of $202.16 and further support at its 200-day MA of $191.81.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices. The Company sells a broad range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard markets vascular, urological, oncological, and surgical specialties products.

Over the past year, CR Bard has traded in a range of $166.29 to $315.18 and is now at $313.67, 89% above that low. The 200-day and 50-day moving averages have moved 0.37% higher and 0.94% higher over the past week, respectively.

SmarTrend recommended that subscribers consider buying shares of CR Bard on December 23rd, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $222.45. Since that recommendation, shares of CR Bard have risen 41.3%. We continue to monitor BCR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows cr bard

Ticker(s): BCR